Citigroup’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.4M | Sell |
112,400
-217,600
| -66% | -$48.3M | 0.01% | 963 |
|
|
2025
Q4 | $75.4M | Buy |
330,000
+84,200
| +34% | +$19.2M | 0.03% | 476 |
|
|
2025
Q3 | $56.9M | Sell |
245,800
-516,400
| -68% | -$105M | 0.03% | 585 |
|
|
2025
Q2 | $141M | Sell |
762,200
-323,600
| -30% | -$60.1M | 0.07% | 260 |
|
|
2025
Q1 | $227M | Sell |
1,085,800
-156,500
| -13% | -$30.4M | 0.12% | 160 |
|
|
2024
Q4 | $221M | Buy |
1,242,300
+930,400
| +298% | +$171M | 0.13% | 146 |
|
|
2024
Q3 | $61.6M | Buy |
311,900
+48,600
| +18% | +$9.07M | 0.04% | 437 |
|
|
2024
Q2 | $45.2M | Sell |
263,300
-95,900
| -27% | -$15.9M | 0.03% | 527 |
|
|
2024
Q1 | $65.4M | Sell |
359,200
-489,400
| -58% | -$84.3M | 0.04% | 381 |
|
|
2023
Q4 | $132M | Buy |
848,600
+44,100
| +5% | +$6.43M | 0.09% | 193 |
|
|
2023
Q3 | $120M | Buy |
804,500
+634,500
| +373% | +$93.1M | 0.09% | 189 |
|
|
2023
Q2 | $22.9M | Buy |
170,000
+70,200
| +70% | +$10.3M | 0.02% | 761 |
|
|
2023
Q1 | $15.9M | Sell |
99,800
-71,800
| -42% | -$11M | 0.01% | 928 |
|
|
2022
Q4 | $27.7M | Sell |
171,600
-2,700
| -2% | -$414K | 0.02% | 644 |
|
|
2022
Q3 | $23.4M | Sell |
174,300
-62,200
| -26% | -$8.93M | 0.02% | 708 |
|
|
2022
Q2 | $36.2M | Sell |
236,500
-537,400
| -69% | -$82.1M | 0.03% | 514 |
|
|
2022
Q1 | $125M | Sell |
773,900
-247,900
| -24% | -$36M | 0.08% | 236 |
|
|
2021
Q4 | $138M | Buy |
1,021,800
+63,000
| +7% | +$7.44M | 0.07% | 236 |
|
|
2021
Q3 | $103M | Buy |
958,800
+102,000
| +12% | +$11.7M | 0.06% | 286 |
|
|
2021
Q2 | $96.5M | Buy |
856,800
+279,400
| +48% | +$31.5M | 0.06% | 303 |
|
|
2021
Q1 | $62.5M | Sell |
577,400
-65,852
| -10% | -$7.04M | 0.04% | 410 |
|
|
2020
Q4 | $68.9M | Buy |
643,252
+157,600
| +32% | +$15.1M | 0.04% | 401 |
|
|
2020
Q3 | $42.5M | Sell |
485,652
-196,588
| -29% | -$18.5M | 0.03% | 516 |
|
|
2020
Q2 | $67M | Buy |
682,240
+11,840
| +2% | +$1.04M | 0.05% | 316 |
|
|
2020
Q1 | $51.1M | Sell |
670,400
-570,700
| -46% | -$48.6M | 0.05% | 345 |
|
|
2019
Q4 | $110M | Buy |
1,241,100
+73,400
| +6% | +$6.09M | 0.08% | 224 |
|
|
2019
Q3 | $88.4M | Buy |
1,167,700
+211,900
| +22% | +$14.5M | 0.07% | 271 |
|
|
2019
Q2 | $69.5M | Buy |
955,800
+648,500
| +211% | +$51M | 0.06% | 322 |
|
|
2019
Q1 | $24.8M | Sell |
307,300
-10,900
| -3% | -$892K | 0.02% | 719 |
|
|
2018
Q4 | $29.3M | Sell |
318,200
-64,100
| -17% | -$5.64M | 0.03% | 620 |
|
|
2018
Q3 | $36.2M | Buy |
382,300
+126,800
| +50% | +$12M | 0.03% | 527 |
|
|
2018
Q2 | $23.7M | Sell |
255,500
-124,400
| -33% | -$12.1M | 0.02% | 704 |
|
|
2018
Q1 | $36M | Sell |
379,900
-53,600
| -12% | -$5.89M | 0.03% | 513 |
|
|
2017
Q4 | $41.9M | Sell |
433,500
-305,200
| -41% | -$28.8M | 0.03% | 490 |
|
|
2017
Q3 | $65.6M | Buy |
738,700
+406,300
| +122% | +$30.9M | 0.05% | 309 |
|
|
2017
Q2 | $24.1M | Sell |
332,400
-448,000
| -57% | -$30.1M | 0.02% | 668 |
|
|
2017
Q1 | $50.9M | Sell |
780,400
-216,772
| -22% | -$13.6M | 0.05% | 353 |
|
|
2016
Q4 | $62.4M | Buy |
997,172
+453,744
| +83% | +$27.7M | 0.06% | 316 |
|
|
2016
Q3 | $34.3M | Sell |
543,428
-49,900
| -8% | -$3.23M | 0.03% | 468 |
|
|
2016
Q2 | $36.7M | Buy |
593,328
+188,820
| +47% | +$11.5M | 0.04% | 407 |
|
|
2016
Q1 | $23.1M | Sell |
404,508
-551,972
| -58% | -$30.8M | 0.03% | 539 |
|
|
2015
Q4 | $56.7M | Sell |
956,480
-37,220
| -4% | -$2.14M | 0.06% | 324 |
|
|
2015
Q3 | $54.1M | Buy |
993,700
+389,828
| +65% | +$25.4M | 0.05% | 323 |
|
|
2015
Q2 | $40.6M | Buy |
603,872
+222,272
| +58% | +$14.5M | 0.04% | 462 |
|
|
2015
Q1 | $22.3M | Sell |
381,600
-250,800
| -40% | -$15.2M | 0.02% | 712 |
|
|
2014
Q4 | $41.4M | Buy |
632,400
+118,700
| +23% | +$7.48M | 0.04% | 477 |
|
|
2014
Q3 | $29.7M | Buy |
513,700
+264,000
| +106% | +$14.7M | 0.03% | 605 |
|
|
2014
Q2 | $14.1M | Buy |
249,700
+41,400
| +20% | +$2.17M | 0.01% | 1017 |
|
|
2014
Q1 | $10.7M | Sell |
208,300
-5,000
| -2% | -$253K | 0.01% | 1104 |
|
|
2013
Q4 | $11.3M | Sell |
213,300
-39,000
| -15% | -$1.92M | 0.01% | 1151 |
|
|
2013
Q3 | $11.3M | Buy |
252,300
+153,500
| +155% | +$6.8M | 0.01% | 1077 |
|
|
2013
Q2 | $4.08M | Buy |
+98,800
| New | +$4.32M | ﹤0.01% | 1799 |
|
Other funds holding ABBV
VCM
VPM
Citigroup's ABBV Position: Q1 2026 in Review
Citigroup increased its AbbVie (ABBV) stake by 27% in Q1 2026, buying an estimated $97.2M and bringing the position to 2,089,885 shares worth $455M. The position accounts for 0.19% of the portfolio, ranked #93.
Citigroup first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $670M in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Citigroup held 2,089,885 shares of AbbVie worth $455M as of Q1 2026.
- Citigroup bought 438,228 AbbVie shares in Q1 2026, an estimated $97.2M.
- AbbVie made up 0.19% of Citigroup's portfolio in Q1 2026, its #93 holding.
- Citigroup first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Citigroup's AbbVie position peaked at $670M in Q1 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.